BRPI0817423A2 - Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto - Google Patents

Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto

Info

Publication number
BRPI0817423A2
BRPI0817423A2 BRPI0817423-7A BRPI0817423A BRPI0817423A2 BR PI0817423 A2 BRPI0817423 A2 BR PI0817423A2 BR PI0817423 A BRPI0817423 A BR PI0817423A BR PI0817423 A2 BRPI0817423 A2 BR PI0817423A2
Authority
BR
Brazil
Prior art keywords
preparing
compound
processes
pharmaceutical formulation
formulation
Prior art date
Application number
BRPI0817423-7A
Other languages
English (en)
Inventor
Lars Eklund
Original Assignee
Cambrex Karlskoga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambrex Karlskoga Ab filed Critical Cambrex Karlskoga Ab
Publication of BRPI0817423A2 publication Critical patent/BRPI0817423A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/825—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups all hydroxy groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
BRPI0817423-7A 2007-10-02 2008-10-02 Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto BRPI0817423A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0719180.2A GB0719180D0 (en) 2007-10-02 2007-10-02 New process
PCT/GB2008/003341 WO2009044143A2 (en) 2007-10-02 2008-10-02 Process for preparing benzofurans

Publications (1)

Publication Number Publication Date
BRPI0817423A2 true BRPI0817423A2 (pt) 2015-06-16

Family

ID=38738973

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817423-7A BRPI0817423A2 (pt) 2007-10-02 2008-10-02 Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto

Country Status (10)

Country Link
US (2) US8519165B2 (pt)
EP (3) EP2200993B1 (pt)
JP (2) JP5577252B2 (pt)
CN (3) CN102382086A (pt)
BR (1) BRPI0817423A2 (pt)
ES (3) ES2559939T3 (pt)
GB (1) GB0719180D0 (pt)
HK (3) HK1164303A1 (pt)
PL (3) PL2200993T3 (pt)
WO (1) WO2009044143A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
EP2280701A2 (en) 2008-04-17 2011-02-09 Sanofi-Aventis Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
WO2010038029A1 (en) * 2008-10-02 2010-04-08 Cambrex Karlskoga Ab New process for preparing diketones and medicaments
CN102171199A (zh) * 2008-10-10 2011-08-31 隆萨有限公司 制备2-烷基-3-芳酰基-5-硝基-苯并呋喃类的方法
CA2745240A1 (en) 2008-12-04 2010-06-10 Sanofi-Aventis Methods and uses involving heme binding protein 1
US9101876B2 (en) 2009-02-25 2015-08-11 Applied Hybrid Energy Pty Ltd. Carbon capture
ES2562004T3 (es) * 2009-04-08 2016-03-02 Cambrex Karlskoga Ab Nuevo procedimiento de preparación de hidroxilaminas y medicamentos
TW201111354A (en) * 2009-05-27 2011-04-01 Sanofi Aventis Process for the production of Dronedarone intermediates
UY32656A (es) 2009-05-27 2010-12-31 Sanofi Aventis Procedimiento para producir benzofuranos
IT1398317B1 (it) * 2010-02-23 2013-02-22 Chimico Internaz Spa Lab Nuovo procedimento per la preparazione del dronedarone.
FR2957079B1 (fr) * 2010-03-02 2012-07-27 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
FR2958290B1 (fr) 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
US20120005128A1 (en) * 2010-06-29 2012-01-05 Sanofi Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
FR2962731B1 (fr) * 2010-07-19 2012-08-17 Sanofi Aventis Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2963006B1 (fr) * 2010-07-21 2013-03-15 Sanofi Aventis Procede de preparation de derives de nitro-benzofurane
EP2452938A1 (en) 2010-11-12 2012-05-16 LEK Pharmaceuticals d.d. Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives
CN102070577B (zh) * 2011-01-19 2016-03-09 上海医药工业研究院 2-正丁基-3-(4-取代丙氧基苯甲酰基)-5-取代氨基苯并呋喃及其应用
CN102070580B (zh) * 2011-01-19 2015-05-20 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-取代氨基苯并呋喃的制备
CN102070581B (zh) * 2011-01-19 2015-11-25 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-氨基苯并呋喃的制备
CN102070578B (zh) * 2011-01-19 2015-10-14 上海医药工业研究院 2-正丁基-3-(4-(3-二正丁基氨基丙氧基)苯甲酰基)-5-烷酰基氨基苯并呋喃的制备方法
WO2012120544A2 (en) 2011-03-10 2012-09-13 Sun Pharmaceutical Industries Ltd. PROCESS FOR N-[2-n-BUTYL-3-[4-[3-(DI-n-BUTYLAMINO) PROPOXY]ENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE HYDROCHLORIDE
FR2973027A1 (fr) * 2011-03-24 2012-09-28 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
HUP1100167A2 (en) * 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
WO2013014480A1 (en) * 2011-07-26 2013-01-31 Sanofi Process for preparation of dronedarone using amide intermediary compound
FR2983198B1 (fr) 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
US9221778B2 (en) 2012-02-13 2015-12-29 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
WO2013121234A1 (en) 2012-02-14 2013-08-22 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
US9382223B2 (en) 2012-02-22 2016-07-05 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
CN102690250A (zh) * 2012-05-08 2012-09-26 郑州明泽医药科技有限公司 决奈达隆中间体及其制备方法
US9238636B2 (en) 2012-05-31 2016-01-19 Sanofi Process for preparation of dronedarone by Grignard reaction

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340300A (en) * 1964-10-05 1967-09-05 American Cyanamid Co Trimethoxy benzoylacetaldehyde oximes
US3558667A (en) * 1968-11-01 1971-01-26 Sterling Drug Inc Benzofurans from o-phenyl ketoximes
JPS60169446A (ja) 1984-02-15 1985-09-02 Mitsui Petrochem Ind Ltd ニトロフエノキシアミン類の製造方法
JPS63139180A (ja) * 1986-12-02 1988-06-10 Tanabe Seiyaku Co Ltd カルボン酸誘導体
JP2982130B2 (ja) * 1990-02-06 1999-11-22 ダイセル化学工業株式会社 β−ケトアミド合成用触媒およびβ−ケトアミドの製造方法
KR0168056B1 (ko) * 1990-04-26 1999-03-20 베르너 발데크 선형 1,3-디케톤의 제조방법
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
DE4244390A1 (de) 1992-12-29 1994-06-30 Basf Ag Verfahren zur Herstellung von Oximino-Derivaten und neue Oximino-Derivate
GB9416219D0 (en) 1994-08-11 1994-10-05 Karobio Ab Receptor ligands
FR2746013B1 (fr) 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
WO1998037068A1 (en) * 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
FR2764800B1 (fr) 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
GB9817118D0 (en) * 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
FR2803846B1 (fr) 2000-01-17 2002-04-05 Clariant France Sa 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, son procede de preparation et son utilisation
US6687428B2 (en) 2000-09-21 2004-02-03 Tera Op (Usa) Inc. Optical switch
FR2817865B1 (fr) 2000-12-11 2005-02-18 Sanofi Synthelabo Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
FR2817750B1 (fr) 2000-12-11 2003-02-21 Sanofi Synthelabo Composition pharmaceutique de dronedarone pour administration parenterale
FR2817864B1 (fr) 2000-12-11 2003-02-21 Sanofi Synthelabo Derive de methanesulfonamido-benzofurane, son procede de preparation et son utilisation comme intermediaire de synthese
WO2002062738A1 (en) 2001-02-02 2002-08-15 Roche Vitamins Ag Process for the purification of 1,3-diketones
JP2002371076A (ja) * 2001-06-14 2002-12-26 Sumitomo Seika Chem Co Ltd ２−アルキル−３−アシルベンゾフラン類の製造方法
IL146389A0 (en) 2001-11-08 2002-07-25 Isp Finetech Ltd Process for the preparation of dronedarone
FR2864536B1 (fr) * 2003-12-24 2006-03-17 Clariant France Sa Procede de preparation de n-alkyl-2 (hydroxy-4-benzoyl)-3 benzofurannes et intermediaires pour sa mise en oeuvre
JPWO2007043401A1 (ja) * 2005-10-07 2009-04-16 キッセイ薬品工業株式会社 含窒素複素環化合物およびそれを含有する医薬組成物
GB0611210D0 (en) 2006-06-07 2006-07-19 Cambrex Karlskoga Ab Process
CN100560067C (zh) 2006-09-29 2009-11-18 北京德众万全药物技术开发有限公司 盐酸决奈达隆口服药物组合物及其制备方法
CN101153012B (zh) 2006-09-29 2010-06-23 北京德众万全药物技术开发有限公司 一种决奈达隆关键中间体的新的制备方法
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
WO2010038029A1 (en) 2008-10-02 2010-04-08 Cambrex Karlskoga Ab New process for preparing diketones and medicaments

Also Published As

Publication number Publication date
PL2388256T3 (pl) 2016-06-30
US8519165B2 (en) 2013-08-27
ES2395174T3 (es) 2013-02-08
HK1164303A1 (zh) 2012-09-21
PL2636670T3 (pl) 2016-12-30
ES2589011T3 (es) 2016-11-08
JP2010540608A (ja) 2010-12-24
JP5943965B2 (ja) 2016-07-05
PL2200993T3 (pl) 2013-01-31
CN101861308A (zh) 2010-10-13
JP2014208660A (ja) 2014-11-06
HK1185611A1 (zh) 2014-02-21
GB0719180D0 (en) 2007-11-14
EP2636670B1 (en) 2016-06-01
CN103342633A (zh) 2013-10-09
EP2388256B1 (en) 2015-11-25
CN101861308B (zh) 2013-06-19
US20130338398A1 (en) 2013-12-19
EP2388256A3 (en) 2012-03-21
EP2636670A1 (en) 2013-09-11
ES2559939T3 (es) 2016-02-16
WO2009044143A2 (en) 2009-04-09
EP2200993B1 (en) 2012-08-29
JP5577252B2 (ja) 2014-08-20
EP2388256A1 (en) 2011-11-23
WO2009044143A3 (en) 2009-06-25
CN102382086A (zh) 2012-03-21
HK1145684A1 (en) 2011-04-29
WO2009044143A4 (en) 2009-09-11
US20100292319A1 (en) 2010-11-18
EP2200993A2 (en) 2010-06-30
CN103342633B (zh) 2016-05-04
US8779201B2 (en) 2014-07-15

Similar Documents

Publication Publication Date Title
BRPI0817423A2 (pt) Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0922174A2 (pt) preparação farmacêutica, uso de uma preparação, e, método para preparar uma preparação farmacêutica
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
BRPI0908221A2 (pt) processo para preparar uma formulação farmacêutica de agentes de contraste
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI1011764A2 (pt) composição farmacêutica, e, método para preparar uma composição farmacêutica
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0906475A2 (pt) Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI1014865A2 (pt) "composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica"
BRPI1016132A2 (pt) composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BRPI0816320A2 (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto de combinação, e, processos para a preparação deu um composto, de uma formulação farmacêutica, e de um produto de combinação
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI0922173A2 (pt) preparação farmacêutica, e, método para preparar uma preparação farmacêutica
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0915473A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0919165A2 (pt) composição farmacêutica,e, uso de um composto
BRPI1007186A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013015085A2 (pt) composição farmacêutica, método para preparar uma composição, e, uso de composição

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 307/80 , C07C 49/78

Ipc: C07D 307/80 (2006.01), C07C 49/78 (2006.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.